This inventor holds 2 USPTO granted patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1999
Title: Susan F Radka: Innovator in Monoclonal Antibodies
Introduction
Susan F Radka is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, her work has the potential to impact various therapeutic applications.
Latest Patents
One of her latest patents involves Anti-oncostatin M monoclonal antibodies. This invention relates to monoclonal antibodies that define Oncostatin M, a novel cytokine. The monoclonal antibodies are capable of binding to Oncostatin M, inhibiting its receptor binding, and/or inhibiting its bioactivity. Such antibodies may be utilized to detect the presence of Oncostatin M and/or to modulate its bioactivities in both in vivo and in vitro systems.
Career Highlights
Susan F Radka is currently associated with Bristol-Myers Squibb Company, where she continues to advance her research in monoclonal antibodies. Her work is crucial in the ongoing development of innovative therapeutic solutions.
Collaborations
She collaborates with notable colleagues such as Mohammed Shoyab and Peter S Linsley, contributing to a dynamic research environment that fosters innovation.
Conclusion
Susan F Radka's contributions to the field of monoclonal antibodies exemplify her dedication to scientific advancement. Her innovative work continues to pave the way for new therapeutic possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile